| RS2142101007 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142101046 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142101078 |
ETFA
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2142101647 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142103306 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142105483 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142105509 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142105542 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142107894 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Nonpapillary renal cell carcinoma |
| RS2142112670 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142117372 |
SUZ12
|
Health Risk |
Pathogenic |
— |
| RS2142117453 |
SUZ12
|
Health Risk |
Pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2142182514 |
COX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex IV deficiency, nuclear type 3 |
| RS2142212748 |
F7
|
Health Risk |
Likely pathogenic |
Factor VII deficiency, Factor VII deficiency |
| RS2142213971 |
SUZ12
|
Health Risk |
Likely pathogenic |
— |
| RS2142215091 |
SUZ12
|
Health Risk |
Likely pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2142215876 |
SUZ12
|
Health Risk |
Likely pathogenic |
Imagawa-Matsumoto syndrome, Non-immune hydrops fetalis |
| RS2142222219 |
SUZ12
|
Health Risk |
Pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2142222377 |
SUZ12
|
Health Risk |
Likely pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2142228734 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142228928 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142228982 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142229072 |
PEX12
|
Health Risk |
Likely pathogenic |
— |
| RS2142229154 |
F7
|
Health Risk |
Likely pathogenic |
Congenital factor VII deficiency, Congenital factor VII deficiency |
| RS2142229406 |
F7
|
Health Risk |
Pathogenic |
— |
| RS2142229513 |
F7
|
Health Risk |
Likely pathogenic |
Factor VII deficiency, Factor VII deficiency |
| RS2142230388 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142230667 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142230890 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142230957 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142231111 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142231201 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142231221 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142231234 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142231614 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS2142232799 |
F7
|
Health Risk |
Likely pathogenic |
Congenital factor VII deficiency, Congenital factor VII deficiency |
| RS2142232898 |
F7
|
Health Risk |
Likely pathogenic |
Congenital factor VII deficiency, Congenital factor VII deficiency |
| RS2142234775 |
F7
|
Health Risk |
Pathogenic |
Factor VII deficiency, Factor VII deficiency |
| RS2142236482 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142236554 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142240125 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142241919 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2142242418 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142243946 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142244823 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142244867 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142245203 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2142250624 |
PALB2
|
Health Risk |
Likely pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2142251164 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142251364 |
PALB2
|
Health Risk |
Likely pathogenic |
Malignant tumor of breast, Hereditary cancer-predisposing syndrome |
| RS2142251406 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2142251992 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142252096 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142252136 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142252484 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142252781 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ovarian carcinoma, Breast and/or ovarian cancer |
| RS2142252950 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142253220 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142253411 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142253567 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142253658 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142254226 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2142254289 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142254584 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142255767 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS2142258855 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142263398 |
EPB42
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS2142263659 |
LIG3
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 20 (mngie type), Mitochondrial DNA depletion syndrome 20 (mngie type) |
| RS2142266216 |
CERS3
|
Health Risk |
Likely pathogenic |
— |
| RS2142271053 |
PALB2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2142271504 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2142271728 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2142271759 |
PALB2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2142272095 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142273197 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142273676 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142274411 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142274423 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142274433 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142274636 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142280018 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142282007 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142283941 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142286963 |
LIG3
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 20 (mngie type), Mitochondrial DNA depletion syndrome 20 (mngie type) |
| RS2142289928 |
MYH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, proximal |
| RS2142290339 |
MYH2
|
Health Risk |
Likely pathogenic |
Myopathy, proximal |
| RS2142290623 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS2142290923 |
USB1
|
Health Risk |
Likely pathogenic |
— |
| RS2142293525 |
MYH2
|
Health Risk |
Likely pathogenic |
Myopathy, proximal |
| RS2142293598 |
MYH2
|
Health Risk |
Pathogenic |
Myopathy, proximal |
| RS2142294288 |
LIG3
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 20 (mngie type), Mitochondrial DNA depletion syndrome 20 (mngie type) |
| RS2142297044 |
MYH2
|
Health Risk |
Pathogenic |
Myopathy, proximal |
| RS2142297368 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2142297728 |
EPB42
|
Health Risk |
Likely pathogenic |
— |
| RS2142298541 |
PALB2
|
Health Risk |
Pathogenic |
Pancreatic cancer, susceptibility to |
| RS2142298948 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142299058 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142299813 |
MYO15A
|
Health Risk |
Pathogenic |
Ear malformation, Ear malformation |
| RS2142299866 |
MYH2
|
Health Risk |
Pathogenic |
Myopathy, proximal |
| RS2142300225 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |